Detalhe da pesquisa
1.
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Am J Hum Genet
; 108(10): 1907-1923, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597585
2.
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Breast Cancer Res
; 23(1): 79, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344426
3.
GENESIS: a French national resource to study the missing heritability of breast cancer.
BMC Cancer
; 16: 13, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26758370
4.
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
J Natl Cancer Inst
; 114(1): 109-122, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320204
5.
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
J Clin Oncol
; 40(14): 1529-1541, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077220
6.
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
Am J Hum Genet
; 81(6): 1186-200, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17999359
7.
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.
Cancer Res
; 80(3): 624-638, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723001
8.
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
J Natl Cancer Inst
; 111(4): 350-364, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312457
9.
Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.
Eur J Hum Genet
; 24(9): 1324-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26785832
10.
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PLoS One
; 11(7): e0158801, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27463617
11.
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
J Clin Oncol
; 33(21): 2345-52, 2015 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26014290
12.
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Front Oncol
; 8: 490, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30430080
13.
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Cancer Epidemiol Biomarkers Prev
; 20(5): 1032-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21393566
14.
Sex ratio among the offspring of BRCA mutation carriers.
JAMA
; 292(6): 687-8, 2004 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-15304464